Moneycontrol PRO

business

USFDA issues Form 483 with 10 observations to Biocon’s Bangalore plant

Regulatory woes continue for Biocon. The United States Foods and Drug Administration (USFDA) issued a form 483 with 10 observations to the Bangalore plant.

first published: Aug 4, 2017 08:31 am

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347
CloseOutskill Genai